Abstract
The mean in vitro lifespan of dermal fibroblast strains derived from cancer-affected individuals belonging to families conforming to the classical Li-Fraumeni-syndrome or the Li-Fraumeni-like syndrome (LF strains), but in whom no TP53 mutation has been found, was not significantly different to that of normal strains. This was in contrast to LF strains that carry TP53 mutations. Cytogenetic observations of numerical and structural chromosome abnormalities were made on Giemsa stained metaphases prepared at different times during the lifespan of strains. Five strains from different LF families showed significantly increased frequencies of abnormal cells during the last 10% of their lifetime compared with seven normal strains and three other LF strains fell outside the normal range but did not reach significance. Two LF strains fell within the normal range indicating heterogeneity of the phenotype in this subset of LF fibroblasts. Numerical aberrations were the major aberration type observed. These observations of genetic instability are similar, but generally less strongly expressed, to those seen in LF strains with TP53 mutations. The basis for genetic instability in LF strains without TP53 mutations is not known, but appears not to involve defects in either the G1 checkpoint or the checkpoint kinase hChk2. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bell D, Szydlo T, Kang D, Wahrer D, Shannon KE, Lubratovitch M, Versilis JJ, Isselbacher KJ, Birch JM, Varley JM, Li FP, Garber JE and Haber DA (1999) Heterozygous germline mutations in hChk2l are a cause of Li-Fraumeni syndrome. Science 286: 2528–2531
Bischoff FZ, Yin SO, Pathak S, Grant G, Siciliano MJ, Giavanella BC, Strong LC and Tainsky MA (1990) Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalisation. Cancer Res 50: 7979–7984
Boyle JM, Mitchell ELD, Greaves MJ, Roberts SA, Tricker K, Varley JM, Birch JM and Scott D (1998) Chromosome instability is a predominant trait of fibroblasts from Li-Fraumeni families. Br J Cancer 77: 2181–2192
Boyle JM, Greaves MJ, Camplejohn RS, Birch JM, Roberts SA and Varley JM (1999) Radiation-induced G1 arrest is not defective in fibroblasts from Li-Fraumeni families without TP53 mutations. Br J Cancer 79: 1657–1664
Burt EC, James LA, Greaves MJ, Birch JM, Boyle JM and Varley JM (2000) Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni Syndrome fibroblasts. Br J Cancer, (in press)
ISCN (1995) An international system for human cytogenetic nomenclature, Mitelman F (ed) S Karger: Basel
Lane DP (1992) Cancer. P53, guardian of the genome. Nature 358: 15–16
Sproston ARM, Boyle JM, Highway J, Birch JM and Scott D (1996) Li-Fraumeni fibroblasts are resistant to low dose-rate irradiation. Int J Radiat Biol 70: 145–150
Varley JM, McGown G, Thomcroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ, Evans DGR and Birch JM (1997) Germline mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res 57: 3245–3252
Williams KJ, Boyle JM, Birch JM, Norton JD and Scott D (1997) Cell cycle arrest defect in Li-Fraumeni syndrome: a mechanism of cancer predisposition? Oncogene 14: 277–282
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Boyle, J., Spreadborough, A., Greaves, M. et al. Chromosome instability in fibroblasts derived from Li–Fraumeni syndrome families without TP53 mutations. Br J Cancer 83, 1136–1138 (2000). https://doi.org/10.1054/bjoc.2000.1444
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1444